300
Participants
Start Date
May 10, 2013
Primary Completion Date
June 15, 2018
Study Completion Date
June 15, 2018
Royal United Hospital; Oncology Department, Bath
City Hospital, Birmingham
Bradford Royal Infirmary; Oncology Department, Bradford
Bristol Haematology and Oncology Centre, Bristol
Queen's Hospital; Oncology Department, Burton-on-Trent
Essex County Hospital, Colchester
Eastborne District General Hospital, Eastbourne
Wonford Hospital; Oncology Department, Exeter
Royal Surrey County Hospital, Guildford
Ipswich Hospital, Ipswich
Airedale General Hospital; Research Office Ward 12, Keighley
St James University Hospital, Leeds
Royal Marsden Hospital - London, London
Maidstone Hospital; Kent Oncology Centre, Maidstone
Christie Hospital Nhs Trust; Medical Oncology, Manchester
The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral
The James Cook University Hospital, Middlesbrough
Mount Vernon Hospital, Middlesex
St Mary's Hospital, Newport
City Campus; Academic Unit of Oncology, Nottingham
Queen Alexandra Hospital; Portsmouth Haematology & Oncology Centre, Level B, Portsmouth
Weston Park Hospital; Cancer Clinical Trials Centre, Sheffield
Southampton General Hospital, Southampton
City General Hospital, Stoke-on-Trent
The Royal Marsden Hospital, Sutton
Singleton Hospital; Oncology, Swansea
Torbay Hospital; Oncology Department, Torquay
Royal Cornwall Hospital, Truro
New Cross Hospital; Deansley Centre, Wolverhampton
The York Hospital, York
Hoffmann-La Roche
INDUSTRY